MetLife Investment Management’s 1Life Healthcare ONEM Stock Holding History

MetLife Investment Management’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-93,948	Closed	-$1.57M	–	2847
2022 Q4	$1.57M	Hold	93,948	–	–	0.01%	1002
2022 Q3	$1.61M	Hold	93,948	–	–	0.01%	973
2022 Q2	$737K	Buy	93,948 +27,749	+42%	+$238K	0.01%	1394
2022 Q1	$733K	Buy	66,199 +24,432	+58%	+$274K	﹤0.01%	1531
2021 Q4	$734K	Hold	41,767	–	–	0.01%	1285
2021 Q3	$846K	Hold	41,767	–	–	0.01%	1211
2021 Q2	$1.38M	Buy	41,767 +10,896	+35%	+$411K	0.01%	1018
2021 Q1	$1.21M	Sell	30,871 -2,436	-7%	-$114K	0.01%	1067
2020 Q4	$1.45M	Hold	33,307	–	–	0.01%	967
2020 Q3	$945K	Buy	33,307 +23,726	+248%	+$749K	0.01%	1055
2020 Q2	$348K	Hold	9,581	–	–	﹤0.01%	1573
2020 Q1	$174K	Buy	+9,581	New	+$210K	﹤0.01%	1776

MetLife Investment Management's ONEM Position: Q1 2023 in Review

MetLife Investment Management sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 93,948 shares — an estimated $1.57M sold.

MetLife Investment Management first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $1.61M in Q3 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

MetLife Investment Management reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
MetLife Investment Management sold 93,948 1Life Healthcare shares in Q1 2023, an estimated $1.57M.
MetLife Investment Management first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
MetLife Investment Management's 1Life Healthcare position peaked at $1.61M in Q3 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.